Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5295)
Perspective Therapeutics, Inc. (CATX)
Lantheus Alpha Therapy, LLC — 10% Owner
Shares
80,783
Price
$3.11
Total Value
$250.90K
Shares Held After
11,440,513
% of Holdings
0.7%
Cigna Group (CI)
Neville Everett — EVP, Special Advisor to the CEO
Shares
617
Price
$284.05
Total Value
$175.26K
Shares Held After
5,053
% of Holdings
10.9%
IRADIMED CORP (IRMD)
ALLEN MONTY K — Director
Shares
405
Price
$86.35
Total Value
$34.97K
Shares Held After
19,581
% of Holdings
2.0%
IRADIMED CORP (IRMD)
ALLEN MONTY K — Director
Shares
1,014
Price
$86.44
Total Value
$87.65K
Shares Held After
19,986
% of Holdings
4.8%
Opus Genetics, Inc. (IRD)
Gagnon Robert E. — Chief Financial Officer
Shares
28,000
Price
$4.54
Total Value
$127.21K
Shares Held After
556,375
% of Holdings
4.8%
Tenon Medical, Inc. (TNON)
HRT FINANCIAL LP — 10% Owner
Shares
1,658
Price
$3.98
Total Value
$6.60K
Shares Held After
3,452
% of Holdings
48.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Huizenga Theodore Alan — SVP, Chief Accounting Officer
Shares
161
Price
$13.99
Total Value
$2.25K
Shares Held After
69,146
% of Holdings
0.2%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
10,000
Price
$4.79
Total Value
$47.90K
Shares Held After
1,070,746
% of Holdings
0.9%
Definium Therapeutics, Inc. (DFTX)
Barrow Robert — Director
Shares
19,023
Price
$37.94
Total Value
$721.73K
Shares Held After
1,494,640
% of Holdings
1.3%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
800
Price
$1.09
Total Value
$872.00
Shares Held After
381,985
% of Holdings
0.2%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
9,961
Price
$221.55
Total Value
$2.21M
Shares Held After
889,851
% of Holdings
1.1%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
6,656
Price
$220.17
Total Value
$1.47M
Shares Held After
899,812
% of Holdings
0.7%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
13,717
Price
$219.41
Total Value
$3.01M
Shares Held After
906,468
% of Holdings
1.5%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
9,721
Price
$218.33
Total Value
$2.12M
Shares Held After
920,185
% of Holdings
1.0%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
14,196
Price
$217.29
Total Value
$3.08M
Shares Held After
929,906
% of Holdings
1.5%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
13,261
Price
$216.38
Total Value
$2.87M
Shares Held After
944,102
% of Holdings
1.4%
ILLUMINA, INC. (ILMN)
Meister Keith A. — Director
Shares
8,439
Price
$215.20
Total Value
$1.82M
Shares Held After
957,363
% of Holdings
0.9%
Beta Bionics, Inc. (BBNX)
Saint Sean — Director
Shares
5,641
Price
$20.08
Total Value
$113.26K
Shares Held After
398,429
% of Holdings
1.4%
Alector, Inc. (ALEC)
Rosenthal Arnon — Director
Shares
72,606
Price
$2.66
Total Value
$193.47K
Shares Held After
2,294,600
% of Holdings
3.1%
Heartflow, Inc. (HTFL)
Verghese Vikram — Chief Financial Officer
Shares
27,540
Price
$49.69
Total Value
$1.37M
Shares Held After
221,143
% of Holdings
11.1%
Alector, Inc. (ALEC)
Wong-Sarad Grace — Principal Accounting Officer
Shares
5,165
Price
$2.67
Total Value
$13.77K
Shares Held After
109,640
% of Holdings
4.5%
Alector, Inc. (ALEC)
Berkley Neil Lindsay — CFO&Chief Business Officer
Shares
29,251
Price
$2.66
Total Value
$77.95K
Shares Held After
350,649
% of Holdings
7.7%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
84,900
Price
$25.32
Total Value
$2.15M
Shares Held After
1,052,083
% of Holdings
7.5%
Caris Life Sciences, Inc. (CAI)
Spetzler David Baxley — President
Shares
393,100
Price
$24.76
Total Value
$9.73M
Shares Held After
1,136,983
% of Holdings
25.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
42
Price
$491.25
Total Value
$20.63K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
940
Price
$490.50
Total Value
$461.07K
Shares Held After
324,485
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,114
Price
$489.62
Total Value
$1.52M
Shares Held After
325,425
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,604
Price
$488.68
Total Value
$783.85K
Shares Held After
328,539
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,429
Price
$487.87
Total Value
$697.16K
Shares Held After
330,143
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
411
Price
$486.72
Total Value
$200.04K
Shares Held After
331,572
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$485.16
Total Value
$116.44K
Shares Held After
331,983
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$483.69
Total Value
$38.70K
Shares Held After
332,223
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$482.35
Total Value
$192.94K
Shares Held After
332,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$481.47
Total Value
$288.88K
Shares Held After
332,703
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$480.53
Total Value
$211.43K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$479.07
Total Value
$95.81K
Shares Held After
333,743
% of Holdings
0.1%
Artiva Biotherapeutics, Inc. (ARTV)
Aslan Fred — Director
Shares
61,888
Price
$11.16
Total Value
$690.39K
Shares Held After
1,473,194
% of Holdings
4.0%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
1,100
Price
$11.16
Total Value
$12.27K
Shares Held After
140,947
% of Holdings
0.8%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
36
Price
$25.81
Total Value
$929.16
Shares Held After
32,316
% of Holdings
0.1%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
3,207
Price
$26.01
Total Value
$83.42K
Shares Held After
32,352
% of Holdings
9.0%
Artiva Biotherapeutics, Inc. (ARTV)
Horan Christopher — Chief Tech Operations Officer
Shares
10,366
Price
$11.16
Total Value
$115.64K
Shares Held After
283,084
% of Holdings
3.5%
Artiva Biotherapeutics, Inc. (ARTV)
Bush Jennifer — COO, CLO, Compliance Officer
Shares
8,391
Price
$11.16
Total Value
$93.61K
Shares Held After
329,529
% of Holdings
2.5%
Editas Medicine, Inc. (EDIT)
O'Neill Gilmore Neil — Director
Shares
5,124
Price
$3.04
Total Value
$15.56K
Shares Held After
243,189
% of Holdings
2.1%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
129
Price
$25.77
Total Value
$3.32K
Shares Held After
27,362
% of Holdings
0.5%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
11,282
Price
$26.01
Total Value
$293.48K
Shares Held After
27,491
% of Holdings
29.1%
Editas Medicine, Inc. (EDIT)
Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Shares
709
Price
$3.04
Total Value
$2.15K
Shares Held After
61,660
% of Holdings
1.1%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
59
Price
$25.78
Total Value
$1.52K
Shares Held After
9,705
% of Holdings
0.6%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
5,130
Price
$26.01
Total Value
$133.45K
Shares Held After
9,764
% of Holdings
34.4%
Editas Medicine, Inc. (EDIT)
Parison Amy — SVP, Chief Financial Officer
Shares
453
Price
$3.04
Total Value
$1.38K
Shares Held After
13,839
% of Holdings
3.2%
Maze Therapeutics, Inc. (MAZE)
Courtney Phillips — GC and Corp. Secretary
Shares
22
Price
$25.78
Total Value
$567.16
Shares Held After
7,007
% of Holdings
0.3%
Showing 651–700 of 5295 transactions (page 14 of 106)